Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Teleperformance SE (“Teleperformance” or the “Company”) (OTCMKTS: TLPFY). Such...
-
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Foghorn Therapeutics Inc. (“Foghorn” or the “Company”) (NASDAQ: FHTX). Such investors...
-
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of LivePerson, Inc. (“LivePerson” or the “Company”) (NASDAQ: LPSN). Such investors are...
-
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of First Republic Bank (“First Republic” or the “Company”) (NYSE: FRC). Such investors are...
-
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rockwell Automation, Inc. (“Rockwell” or the “Company”) (NYSE: ROK). Such investors are...
-
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of LPL Financial Holdings Inc. (“LPL” or the “Company”) (NASDAQ: LPLA). Such investors are...
-
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Incyte Corporation (“Incyte” or the “Company”) (NASDAQ: INCY). Such investors are advised...
-
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cutera, Inc. (“Cutera” or the “Company”) (NASDAQ: CUTR). Such investors are advised to...
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Block, Inc. – SQ
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Block, Inc. (“Block” or the “Company”) (NYSE: SQ). Such investors are advised to contact...
-
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are...